Literature DB >> 18789386

Human cerebral neuropathology of Type 2 diabetes mellitus.

Peter T Nelson1, Charles D Smith, Erin A Abner, Frederick A Schmitt, Stephen W Scheff, Gregory J Davis, Jeffrey N Keller, Gregory A Jicha, Daron Davis, Wang Wang-Xia, Adria Hartman, Douglas G Katz, William R Markesbery.   

Abstract

The cerebral neuropathology of Type 2 diabetes (CNDM2) has not been positively defined. This review includes a description of CNDM2 research from before the 'Pubmed Era'. Recent neuroimaging studies have focused on cerebrovascular and white matter pathology. These and prior studies about cerebrovascular histopathology in diabetes are reviewed. Evidence is also described for and against the link between CNDM2 and Alzheimer's disease pathogenesis. To study this matter directly, we evaluated data from University of Kentucky Alzheimer's Disease Center (UK ADC) patients recruited while non-demented and followed longitudinally. Of patients who had come to autopsy (N = 234), 139 met inclusion criteria. These patients provided the basis for comparing the prevalence of pathological and clinical indices between well-characterized cases with (N = 50) or without (N = 89) the premortem diagnosis of diabetes. In diabetics, cerebrovascular pathology was more frequent and Alzheimer-type pathology was less frequent than in non-diabetics. Finally, a series of photomicrographs demonstrates histopathological features (including clinical-radiographical correlation) observed in brains of persons that died after a history of diabetes. These preliminary, correlative, and descriptive studies may help develop new hypotheses about CNDM2. We conclude that more work should be performed on human material in the context of CNDM2.

Entities:  

Mesh:

Year:  2008        PMID: 18789386      PMCID: PMC2834412          DOI: 10.1016/j.bbadis.2008.08.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  234 in total

1.  Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic.

Authors:  Geert Jan Biessels; Aafke Koffeman; Philip Scheltens
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

2.  Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study.

Authors:  J Heitner; D Dickson
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

3.  Alzheimer disease: curly fibers and tangles in organs other than brain.

Authors:  J Miklossy; K Taddei; R Martins; G Escher; R Kraftsik; O Pillevuit; D Lepori; M Campiche
Journal:  J Neuropathol Exp Neurol       Date:  1999-08       Impact factor: 3.685

Review 4.  Cerebrovascular disease in the elderly: lipoprotein metabolism and cognitive decline.

Authors:  Francesco Panza; Vincenzo Solfrizzi; Anna M Colacicco; Alessia D'Introno; Cristiano Capurso; Rossella Palasciano; Orlando Todarello; Sabrina Capurso; Vincenza Pellicani; Antonio Capurso
Journal:  Aging Clin Exp Res       Date:  2006-04       Impact factor: 3.636

Review 5.  Diabetic neuropathy.

Authors:  D A Greene; A F Sima; M A Pfeifer; J W Albers
Journal:  Annu Rev Med       Date:  1990       Impact factor: 13.739

Review 6.  Hypoglycemic brain damage.

Authors:  Roland N Auer
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

7.  Changes in extra- and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hypoglycemic rats.

Authors:  M L Smith; R von Hanwehr; B K Siesjö
Journal:  J Cereb Blood Flow Metab       Date:  1986-10       Impact factor: 6.200

8.  Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging.

Authors:  Chris MacKnight; Kenneth Rockwood; Erin Awalt; Ian McDowell
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

Review 9.  Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels.

Authors:  Augustina M A Brands; Roy P C Kessels; Edward H F de Haan; L Jaap Kappelle; Geert Jan Biessels
Journal:  Eur J Pharmacol       Date:  2004-04-19       Impact factor: 4.432

10.  Wallerian degeneration of the corticospinal tracts: postmortem MR-pathologic correlations.

Authors:  E Matsusue; S Sugihara; S Fujii; T Kinoshita; E Ohama; T Ogawa
Journal:  Acta Radiol       Date:  2007-07       Impact factor: 1.990

View more
  81 in total

Review 1.  Obesity, leptin, and Alzheimer's disease.

Authors:  Edward B Lee
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

2.  Lessons in the study of Alzheimer's disease: a tribute to Dr. William R. Markesbery.

Authors:  Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  Neuromolecular Med       Date:  2010-07-17       Impact factor: 3.843

3.  Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance.

Authors:  H Bruehl; V Sweat; J Hassenstab; V Polyakov; A Convit
Journal:  J Clin Exp Neuropsychol       Date:  2010-06       Impact factor: 2.475

Review 4.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

5.  Ethnicity/culture modulates the relationships of the haptoglobin (Hp) 1-1 phenotype with cognitive function in older individuals with type 2 diabetes.

Authors:  Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Hadas Hoffman; Rachel Preiss; Keren Koifmann; Lior Greenbaum; Andrew Levy; Jeremy M Silverman; Derek Leroith; Mary Sano; Michal Schnaider-Beeri
Journal:  Int J Geriatr Psychiatry       Date:  2015-09-21       Impact factor: 3.485

Review 6.  Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms.

Authors:  Elizabeth Guerrero-Berroa; James Schmeidler; Michal Schnaider Beeri
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-30       Impact factor: 4.600

7.  Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology.

Authors:  Jeremy J Pruzin; Julie A Schneider; Ana W Capuano; Sue E Leurgans; Lisa L Barnes; Rexford S Ahima; Steven E Arnold; David A Bennett; Zoe Arvanitakis
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jan-Mar       Impact factor: 2.703

8.  High Blood Lead Levels: An Increased Risk for Development of Brain Hyperintensities among Type 2 Diabetes Mellitus Patients.

Authors:  Hafsa Suhail Najim Al-Anbari; Dawser K Ismail; Mohammed Khudair Hasan; Qutaiba Ahmed Al Khames Aga; Pottathil Shinu; Anroop B Nair
Journal:  Biol Trace Elem Res       Date:  2020-08-31       Impact factor: 3.738

Review 9.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10

10.  Caffeine prevents weight gain and cognitive impairment caused by a high-fat diet while elevating hippocampal BDNF.

Authors:  Gregory A Moy; Ewan C McNay
Journal:  Physiol Behav       Date:  2012-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.